NAGE - niagenbioscience.com Long-Term Debt Volume

Graphic logo of ChromaDex (NAGE)

The Chromadex Corp (NAGE) price chart serves as an indicator for the NAD+ nutraceutical manufacturer, which is implementing autonomous laboratories to control compound purity despite raw material supply challenges and FDA regulatory hurdles. The current metric is 0.00. Exclusive molecular patents and long-term partner agreements ensure business stability, creating a protected niche within the cellular health sector.

NAGE ChromaDex Corp Company Long-Term Debts (03/20/2025 - 10/29/2026)

niagenbioscience.com - analytical breakdowns and key metrics (NAGE)

- share price and expert price forecast:
Share Price ChromaDex Corporation|NAGE - Analyst Consensus Forecast
- market capitalization statistics:
Market Capitalization ChromaDex|NAGE - Enterprise Value
- balance sheet equity data:
Accounting Value per Share ChromaDex|NAGE - Book Capitalization|Market Capitalization to Book Value Ratio niagenbioscience.com|NAGE - Aggregate Company Assets
- business debt structure and liquidity details:
Debt to Equity Chromadex Corp|NAGE - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital ChromaDex|NAGE - Company Aggregate Debts|Debts to Net Assets ChromaDex|NAGE - Company Long-Term Debt|Company Short-Term Indebtedness ChromaDex|Interim Coverage Ratio niagenbioscience.com
- earnings and multiples data:
NAGE - Net Income
Summary company analytics:NAGE ChromaDex Corp
Manufactured products of niagenbioscience.com

The price action of long-term loans and borrowings for Chromadex Corp (NAGE) demonstrates a financing strategy for expansion within the longevity sector amid a change in leadership. This indicator aggregates liabilities with maturities exceeding one year, measuring debt load and the risk of cash flow gaps; for an investor, an increase in this metric signifies either aggressive scaling of development or a critical overheating of the balance sheet should monetization slow down.

Competitors of Chromadex Corp (NAGE)

ISRG: Company Long-Term Indebtedness|Danaher - Company Long-Term Debts|Long-Term Debt Volume BD BDX|STE: Company Long-Term Debts|Company Long-Term Liabilities West Pharma Corp|BAX (Baxter International) - Company Long-Term Debts|Company Long-Term Debts masimo.com|Company Long-Term Debt Stevanato Group (STVN)|Company Long-Term Debt TFX (Teleflex Inc.)|Merit Medical Systems Inc - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings NVST|ICU Medical, Inc. - Company Long-Term Debts|Long-Term Debt Volume dentsplysirona.com XRAY|LeMaitre Vascular (LMAT) - Company Long-Term Debt|Company Long-Term Indebtedness ATRC|Company Long-Term Debt STAAR Surgical Corp|ZimVie Corp (ZIMV) - Long-Term Debt Volume|Company Long-Term Liabilities ANGO (AngioDynamics, Inc.)|Amount of Long-Term Liabilities CERS|Company Long-Term Debt Teknova TKNO|Company Long-Term Loans and Borrowings MGRM|STSS: Company Long-Term Liabilities|INFU - Company Long-Term Debts|Utah Medical Products (UTMD) - Company Long-Term Debt|Company Long-Term Liabilities KORU Medical|NYXH (Nyxoah) - Company Long-Term Debts|Long-Term Debt Microbot Medical, Inc. MBOT|Company Long-Term Debt Pro-Dex Corp (PDEX)|Zentek Corp - Company Long-Term Indebtedness|Elutia Inc. - Company Long-Term Liabilities|Amount of Long-Term Liabilities MLSS (milestonescientific.com)|NXGL - Company Long-Term Debt|Long-Term Debt Volume Retractable Technologies RVP|HBIO: Company Long-Term Debts|Company Long-Term Liabilities Femasys Corporation|MHUA (Meihua Medical Technologies) - Company Long-Term Debts|POAI: Company Long-Term Loans and Borrowings|Company Long-Term Debt Callan JMB Inc (CJMB)|ATRI (Atrion Corp.) - Company Long-Term Loans and Borrowings|Company Long-Term Debt NeuroMetrix Corp NURO